Back to CLDX Stock Lookup

Celldex Therapeutics (CLDX) – Company Press Releases

Mar 17, 2015 08:01 AM Celldex Therapeutics Announces Clinical Trial Collaboration with Roche to Evaluate the Combination of Varlilumab and MPDL3280A
Mar 3, 2015 10:00 AM Celldex Therapeutics Announces Upcoming Presentation at the Cowen and Company 35th Annual Health Care Conference
Feb 27, 2015 01:25 PM Celldex Announces Exercise of Underwriters' Option to Purchase Additional Shares
Feb 27, 2015 01:25 PM Celldex Announces Exercise of Underwriters' Option to Purchase Additional Shares
Feb 25, 2015 06:48 PM Celldex Therapeutics Prices Public Offering of Common Stock
Feb 25, 2015 06:48 PM Celldex Therapeutics Prices Public Offering of Common Stock
Feb 24, 2015 04:00 PM Celldex Therapeutics Announces Proposed Public Offering of Common Stock
Feb 24, 2015 04:00 PM Celldex Therapeutics Announces Proposed Public Offering of Common Stock
Feb 24, 2015 07:00 AM Celldex Reports Fourth Quarter and Year-End 2014 Results
Feb 23, 2015 08:01 AM Celldex's Rindopepimut (Rintega(R)) Receives FDA Breakthrough Therapy Designation for the Treatment of Adult Patients with EGFRvIII-positive Glioblastoma
Feb 19, 2015 04:01 PM Celldex to Report Fourth Quarter and Fiscal 2014 Business/Financial Results and Host 2015 Corporate Strategy Conference Call
Feb 19, 2015 04:01 PM Celldex to Report Fourth Quarter and Fiscal 2014 Business/Financial Results and Host 2015 Corporate Strategy Conference Call
Feb 9, 2015 08:00 AM Celldex Therapeutics Announces Upcoming Presentation at the 2015 Leerink Global Healthcare Conference
Jan 29, 2015 08:00 AM Celldex Therapeutics and Bristol Myers-Squibb Announce Initiation of Phase 1/2 Combination Study of Varlilumab and Opdivo(R) in Advanced Refractory Solid Tumors
Dec 4, 2014 04:01 PM Celldex Therapeutics Initiates a Phase 2 Study of Glembatumumab Vedotin in Patients with Advanced Melanoma
Nov 7, 2014 10:01 AM Celldex Presents Varlilumab Proof of Concept Data at SITC Annual Meeting 2014
Nov 4, 2014 04:01 PM Celldex Reports Third Quarter 2014 Results
Sep 25, 2014 08:05 AM Celldex Therapeutics Initiates Pilot Study of CDX-301 in Allogeneic Hematopoietic Stem Cell Transplantation
Sep 3, 2014 02:00 PM Celldex Announces Upcoming Presentation at the Morgan Stanley Healthcare Conference
Aug 6, 2014 04:01 PM Celldex Reports Second Quarter 2014 Results
Jul 30, 2014 08:03 AM Celldex Therapeutics Announces Senior Leadership Promotions
Jul 18, 2014 08:03 AM Celldex to Report Second Quarter 2014 Financial Results and Host Corporate 2014 Objectives Update Call
May 28, 2014 11:00 AM Celldex Therapeutics to Present at the Jefferies 2014 Global Healthcare Conference
May 14, 2014 05:01 PM Celldex Therapeutics Announces Varlilumab (CDX-1127) Phase 1 Clinical Data to be Presented at ASCO Annual Meeting 2014
May 2, 2014 11:45 AM Celldex to Present at Two Upcoming Investor Conferences

Back to CLDX Stock Lookup